Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Liver cancer
Closed
Phase 2
This trial is for people with hepatocellular carcinoma (HCC), a type of liver cancer. It is comparing two treatments.
One treatment is a combination of a cancer vaccine, chemotherapy and chemoembolisation. The other treatment is chemotherapy and chemoembolisation. The researchers want to find which is better.
Recruitment start: 1 December 2015
Recruitment end: 30 September 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor David Adams
Experimental Cancer Medicine Centre (ECMC)
NIHR Efficacy and Mechanism Evaluation (EME) Programme
University of Birmingham
Last reviewed: 20 August 2024
CRUK internal database number: 9660
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
